• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/12/25 8:00:00 PM ET
    $ALNY
    $BIIB
    $CDW
    $FER
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ALNY alert in real time by email

    NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NDX®), which will become effective prior to market open on Monday, December 22, 2025.

    The following six companies will be added to the Index: Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Ferrovial SE (NASDAQ:FER), Insmed Incorporated (NASDAQ:INSM), Monolithic Power Systems, Inc. (NASDAQ:MPWR), Seagate Technology Holdings plc (NASDAQ:STX), Western Digital Corp. (NASDAQ:WDC).

    The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies listed on the Nasdaq Stock Market® encompassing a diverse range of industries and sectors. From technology and retail to healthcare, telecommunications, biotechnology, and media, these companies collectively shape the new 21st century economy. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    As of December 2025, the Nasdaq-100 Index underpins more than 200 tracking products with over $600 billion in assets under management globally, including the Invesco QQQ Trust (QQQ®), which seeks to deliver investment results that, before expenses, correspond to the performance of the Nasdaq-100 Index. In addition to QQQ, a range of derivatives and structured instruments, such as futures, options, and other products based on the Nasdaq-100 Index and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following six companies will be removed from the Index: Biogen Inc. (NASDAQ:BIIB), CDW Corporation (NASDAQ:CDW), GlobalFoundries Inc. (NASDAQ:GFS), Lululemon Athletica Inc. (NASDAQ:LULU), ON Semiconductor Corporation (NASDAQ:ON), The Trade Desk, Inc. (NASDAQ:TTD).

    Information

    For information about the six companies to be added to the Nasdaq-100 Index, please visit the following respective company websites:

    • Alnylam Pharmaceuticals, Inc. – https://www.alnylam.com/
    • Ferrovial SE – https://www.ferrovial.com/
    • Insmed Incorporated – https://insmed.com/
    • Monolithic Power Systems, Inc. – https://www.monolithicpower.com/
    • Seagate Technology Holdings plc – https://www.seagate.com/
    • Western Digital Corp. – https://www.westerndigital.com/



    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic, and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com

    Nasdaq®, Nasdaq-100 Index®, Nasdaq-100®, NDX®, QQQ®, and Nasdaq Stock Market® are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding Nasdaq-listed companies or Nasdaq proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    Media Relations Contact Investor Relations Contact
    Name: Maximilian Leitenberger

    Email: Maximilian.leitenberger@nasdaq.com



     Name: Index Client Services

    Email: indexservices@nasdaq.com

       

    NDAQF



    Primary Logo

    Get the next $ALNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNY
    $BIIB
    $CDW
    $FER

    CompanyDatePrice TargetRatingAnalyst
    lululemon athletica inc.
    $LULU
    7/16/2026$94.00Hold → Sell
    Truist
    Seagate Technology Holdings PLC
    $STX
    7/13/2026$1150.00 → $1240.00Buy
    Citigroup
    Biogen Inc.
    $BIIB
    7/13/2026$235.00Hold → Buy
    Truist
    Seagate Technology Holdings PLC
    $STX
    7/10/2026$1100.00Equal Weight → Overweight
    Wells Fargo
    The Trade Desk Inc.
    $TTD
    6/30/2026$11.60Neutral → Sell
    Arete
    Western Digital Corporation
    $WDC
    6/29/2026$1050.00Buy
    Melius
    Seagate Technology Holdings PLC
    $STX
    6/29/2026$1600.00Buy
    Melius
    ON Semiconductor Corporation
    $ON
    6/26/2026$110.00Buy → Hold
    TD Cowen
    More analyst ratings

    $ALNY
    $BIIB
    $CDW
    $FER
    SEC Filings

    View All

    SEC Form 144 filed by GlobalFoundries Inc.

    144 - GLOBALFOUNDRIES Inc. (0001709048) (Subject)

    7/20/26 9:44:21 AM ET
    $GFS
    Semiconductors
    Technology

    Insmed Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - INSMED Inc (0001104506) (Filer)

    7/16/26 7:00:46 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Monolithic Power Systems Inc.

    SCHEDULE 13G - MONOLITHIC POWER SYSTEMS INC (0001280452) (Subject)

    7/15/26 3:52:57 PM ET
    $MPWR
    Semiconductors
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    lululemon athletica downgraded by Truist with a new price target

    Truist downgraded lululemon athletica from Hold to Sell and set a new price target of $94.00

    7/16/26 8:46:27 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Citigroup reiterated coverage on Seagate Tech with a new price target

    Citigroup reiterated coverage of Seagate Tech with a rating of Buy and set a new price target of $1,240.00 from $1,150.00 previously

    7/13/26 10:00:24 AM ET
    $STX
    Electronic Components
    Technology

    Biogen upgraded by Truist with a new price target

    Truist upgraded Biogen from Hold to Buy and set a new price target of $235.00

    7/13/26 8:58:02 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Strategy Officer Hogan Michael James bought $767 worth of Ordinary Shares (12 units at $61.41), increasing direct ownership by 2% to 807 units (SEC Form 4)

    4 - GLOBALFOUNDRIES Inc. (0001709048) (Issuer)

    7/20/26 5:09:45 PM ET
    $GFS
    Semiconductors
    Technology

    Director Bergh Charles V bought $500,384 worth of shares (4,275 units at $117.05) (SEC Form 4)

    4 - lululemon athletica inc. (0001397187) (Issuer)

    6/16/26 5:55:44 PM ET
    $LULU
    Apparel
    Consumer Discretionary

    Large owner Investor Ab bought $4,882,116 worth of shares (56,782 units at $85.98) (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    6/15/26 4:30:19 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    $ALNY
    $BIIB
    $CDW
    $FER
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Georgia's Five Largest Banks to Transform Treasury Infrastructure in Landmark Partnership Between Nasdaq Calypso and The National Bank of Georgia

    TBILISI, Georgia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced a landmark partnership with the National Bank of Georgia (NBG) to modernize the treasury and financial markets infrastructure across Georgia's banking sector. Five of the country's largest commercial banks — Bank of Georgia, TBC Bank, Liberty Bank, Terabank and Basisbank — will adopt the Nasdaq Calypso platform under a shared, common infrastructure model spanning the full front-to-back trade lifecycle. The initiative, operating under the Georgian Market Advancement Program (GMAP) and coordinated in collaboration with the Georgian Financial Markets Treasuries' Association (GFMTA), represent

    7/20/26 3:00:00 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    MaxsMaking Inc. Notified of Anticipated Delisting from The Nasdaq Stock Market

    NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (NASDAQ:NDAQ) announced today that it has notified MaxsMaking Inc. (NASDAQ:MAMK) that its securities will be delisted from the Nasdaq Stock Market LLC on July 28, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market.  Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission (https://www.sec.gov/files/litigation/suspensions/2025/34-104180.pdf) Nasdaq

    7/17/26 4:05:00 PM ET
    $NDAQ
    $MAMK
    Investment Bankers/Brokers/Service
    Finance
    Apparel
    Consumer Discretionary

    The Trade Desk Appoints Ron Lamprecht as Chief Business Development Officer, Senior Vice President

    The Trade Desk, a leading global advertising technology company, today announced the appointment of Ron Lamprecht as Chief Business Development Officer and Senior Vice President. In this newly created role, Lamprecht will build strategic partnerships that expand our market opportunity, develop new commercial models and enterprise-wide global opportunities. He will report to Chief Operating Officer Vivek Kundra and be based in New York City. Lamprecht brings more than 25 years of experience driving growth and strategic partnerships across the technology and media industries. Most recently, he spent seven years as Director of Corporate Business Development at Amazon leading strategic initia

    7/17/26 9:00:00 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Strategy Officer Hogan Michael James bought $767 worth of Ordinary Shares (12 units at $61.41), increasing direct ownership by 2% to 807 units (SEC Form 4)

    4 - GLOBALFOUNDRIES Inc. (0001709048) (Issuer)

    7/20/26 5:09:45 PM ET
    $GFS
    Semiconductors
    Technology

    Chief Legal Officer Azar Samak L sold $19,825 worth of Ordinary Shares (335 units at $59.18) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 12,479 units (SEC Form 4)

    4 - GLOBALFOUNDRIES Inc. (0001709048) (Issuer)

    7/20/26 5:03:24 PM ET
    $GFS
    Semiconductors
    Technology

    EVP, WW Sales & Marketing Sciammas Maurice sold $20,245,937 worth of shares (15,000 units at $1,349.73) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 151,644 units (SEC Form 4)

    4 - MONOLITHIC POWER SYSTEMS, INC. (0001280452) (Issuer)

    7/17/26 5:43:36 PM ET
    $MPWR
    Semiconductors
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ARIKAYCE KIT issued to INSMED INC

    Submission status for INSMED INC's drug ARIKAYCE KIT (SUPPL-25) with active ingredient AMIKACIN SULFATE has changed to 'Approval' on 06/25/2026. Application Category: NDA, Application Number: 207356, Application Classification: Labeling

    6/29/26 4:48:07 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZURZUVAE issued to BIOGEN INC

    Submission status for BIOGEN INC's drug ZURZUVAE (SUPPL-3) with active ingredient ZURANOLONE has changed to 'Approval' on 04/20/2026. Application Category: NDA, Application Number: 217369, Application Classification: Labeling

    4/23/26 6:14:48 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Leadership Updates

    Live Leadership Updates

    View All

    The Trade Desk Appoints Ron Lamprecht as Chief Business Development Officer, Senior Vice President

    The Trade Desk, a leading global advertising technology company, today announced the appointment of Ron Lamprecht as Chief Business Development Officer and Senior Vice President. In this newly created role, Lamprecht will build strategic partnerships that expand our market opportunity, develop new commercial models and enterprise-wide global opportunities. He will report to Chief Operating Officer Vivek Kundra and be based in New York City. Lamprecht brings more than 25 years of experience driving growth and strategic partnerships across the technology and media industries. Most recently, he spent seven years as Director of Corporate Business Development at Amazon leading strategic initia

    7/17/26 9:00:00 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    The Trade Desk Appoints Vinny Rinaldi as Vice President of Client Strategy & Growth

    Industry veteran brings decades of marketing, data and digital transformation experience to help brands maximize business outcomes in the AI eraThe Trade Desk, a leading advertising technology company, today announced that Vinny Rinaldi has joined the company as Vice President of Client Strategy & Growth. In this role, Rinaldi will partner closely with marketers to help them unlock greater value from data-driven advertising, navigate the rapidly evolving media landscape and accelerate business growth through the premium open internet. Rinaldi will report to Chief Operating Officer, Vivek Kundra.Rinaldi joins The Trade Desk with more than two decades of experience leading marketing transforma

    7/16/26 9:00:00 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    The Trade Desk Appoints Kristi Argyilan as Chief Commercial Officer, Executive Vice President

    Industry veteran joins as a pioneer of retail and commerce data; Argyilan is third new C-level hire in recent monthsThe Trade Desk, a leading global advertising technology company, today announced the appointment of Kristi Argyilan as Chief Commercial Officer and Executive Vice President. Argyilan will lead The Trade Desk’s data partnerships team, including identity, measurement, retail media, governance and more. She will report into founder and CEO, Jeff Green and be based in San Francisco.Argyilan joins The Trade Desk as one of the advertising industry's most respected leaders in retail media and commerce. Most recently, she served as Global Head of Advertising at Uber, where she led the

    7/15/26 9:00:00 AM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    $ALNY
    $BIIB
    $CDW
    $FER
    Financials

    Live finance-specific insights

    View All

    onsemi to Announce Second Quarter Financial Results

    SCOTTSDALE, Ariz., July 16, 2026 (GLOBE NEWSWIRE) -- onsemi (Nasdaq: ON) plans to announce its financial results for the second quarter, which ended July 3, 2026, after market close on Monday, August 3, 2026. The company will host a conference call at 5 p.m. Eastern Time (ET) on August 3, 2026, following the release of its financial results. Investors and interested parties can access the conference call in the following manner: Webcast: A live webcast of the conference call will be available via the "Investor Relations" section of the company’s website at http://www.onsemi.com. The re-broadcast of the call will be available at this site approximately one hour following the live broadcas

    7/16/26 4:15:00 PM ET
    $ON
    Semiconductors
    Technology

    Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results

    Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the second quarter ending June 30, 2026 on Thursday, July 30, 2026, before the U.S. financial markets open. Management will provide an update on the Company and discuss second quarter 2026 results as well as expectations for the future via conference call on Thursday, July 30, 2026 at 8:30 am ET. A live audio webcast of the call will be available on the Investors section of the Company’s website at www.alnylam.com/events. An archived webcast will be available on the Alnylam website approximately two hours after the event. About Alnylam Pharmaceuti

    7/16/26 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension

    –12-Month Data Demonstrated Sustained Improvement with TPIP Across All Secondary Efficacy Measures Including Reduction in Mortality Risk Status by REVEAL Lite 2.0– –Placebo Crossed Group Demonstrated Treatment Response on TPIP, Achieving Similar Outcomes to the TPIP Continued Group by Month 12––TPIP Was Safe and Well-tolerated with No Newly Identified Safety Signals through Month 12; Doses Up to 1,280 µg Once Daily Were Permitted in the OLE Study––These OLE Data, Combined with Once-Daily Inhaled Administration, Reinforce TPIP's Potential to Become the Prostanoid of Choice for Patients with PAH––Insmed to Host Investor Call Thursday, July 16, 2026, at 8:00 a.m. ET–BRIDGEWATER, N.J., July 16,

    7/16/26 7:00:00 AM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BIIB
    $CDW
    $FER
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Trade Desk Inc.

    SC 13G/A - Trade Desk, Inc. (0001671933) (Subject)

    11/14/24 4:42:28 PM ET
    $TTD
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13G/A filed by Insmed Incorporated

    SC 13G/A - INSMED Inc (0001104506) (Subject)

    11/14/24 1:22:37 PM ET
    $INSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Western Digital Corporation

    SC 13G/A - WESTERN DIGITAL CORP (0000106040) (Subject)

    11/14/24 1:22:34 PM ET
    $WDC
    Electronic Components
    Technology